May 21, 2020 / 10:14 AM / 13 days ago

BRIEF-Synlogic Announces Termination Of Abbvie Collaboration Agreement

May 21 (Reuters) - Synlogic Inc:

* SYNLOGIC ANNOUNCES TERMINATION OF ABBVIE COLLABORATION AGREEMENT

* SYNLOGIC INC - TERMINATION OF DEAL WITH ABBVIE FOR DEVELOPMENT OF SYNTHETIC BIOTIC MEDICINES FOR POTENTIAL TREATMENT OF INFLAMMATORY BOWEL DISEASE

* SYNLOGIC INC - ABBVIE AND SYNLOGIC HAVE BEEN PROSECUTING SPECIFIED SYNTHETIC BIOTIC PROGRAMS THROUGH DISCOVERY ACTIVITIES

* SYNLOGIC INC - ABBVIE, CO HAVE DECIDED TO TERMINATE THEIR COLLABORATION ON PROGRAMS

* SYNLOGIC INC - SYNLOGIC FURTHER REGAINS RIGHTS TO PARTNER ITS IBD PROGRAMS

* SYNLOGIC - UPON TERMINATION, SYNLOGIC REGAINS ALL RIGHTS TO DEVELOP PROGRAMS AND NEW IBD SYNTHETIC BIOTIC MEDICINES FOR ALL EFFECTORS TARGETING IBD Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below